Conchillo M, de Knegt RJ, Payeras M, Quiroga J, Sangro B, Herrero JI, Castilla-Cortazar I, Frystyk J, Flyvbjerg A, Yoshizawa C: Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: results of a pilot randomized controlled clinical trial
That's not a reason to dismiss the product - smaller doses still feed gut bacteria - but it is a reason to calibrate your expectations honestly and not assume the supplement will produce the same results as those reported in gram-level clinical trials
The following combinations of subject headings and free-text terms were used: diabetes mellitus type 2 and renal insufficiency, chronic and sodium-glucose transporter 2 inhibitors, dipeptidyl-peptidase 4 inhibitors, glucagon-like peptide 1, and randomized controlled trials
almost 1 in 8 U.S
The referral destination depends on the accompanying findings: liver findings may point to hepatology or gastroenterology, significant kidney disease to nephrology, abnormal counts or smear findings to hematology, and cancer concern to oncology